CD4<sup>+</sup> assessment may improve risk stratification in cirrhosis; however, prospective, multicenter studies are warranted to validate these findings and to evaluate CD4-guided strategies for the prevention of opportunistic infections. The gene discussed is CD4; the disease is Cirrhosis.